Form 4: Aethlon Medical Director Forfeits Shares for Tax Withholding

Aethlon Medical Director Edward G. Broenniman forfeited 89 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Summary

• Edward G. Broenniman, a Director at Aethlon Medical Inc. (AEMD), reported a transaction on March 31, 2026.
• He forfeited 89 shares of common stock at a price of $2.19 per share.
• This forfeiture was to cover tax withholdings upon the conversion of an aggregate of 357 vested and outstanding restricted stock units into common stock.
• Following this transaction, Broenniman beneficially owns 1,915 shares of AEMD common stock directly.
• The restricted stock units were part of a grant previously reported in a Form 4 filing on April 25, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine administrative transaction related to executive compensation rather than a strategic move or performance indicator.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. This specific filing indicates a routine tax-related event for a director's equity compensation, which is common across industries for executives receiving restricted stock units. It does not provide insight into broader industry trends for Aethlon Medical's sector.

Comparison to Industry Standards

• This transaction is a standard administrative event related to executive compensation, consistent with practices observed across publicly traded companies where equity awards are part of compensation packages.

Related Party Transactions

• The transaction involves a director of the company, Edward G. Broenniman, and is related to his equity compensation, which is a common form of related party transaction in the context of executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine administrative transaction related to executive compensation and not a discretionary sale or purchase.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

Recommendation

This Form 4 filing details a routine administrative transaction where a director forfeited shares to cover tax obligations arising from the conversion of restricted stock units. Such an event is common for executives with equity compensation and does not typically signal a change in the company's fundamental prospects or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to alter an existing investment thesis.

Keywords

Aethlon Medical, AEMD, Form 4, Insider Transaction, Stock Forfeiture, Restricted Stock Units, Tax Withholding, Director, Beneficial Ownership